MyoPax Receives FDA Orphan Drug Designation for Regenerative Cell Therapy
26 Jul 2023 //
BUSINESSWIRE
MyoPax Receives Rare Pediatric Disease Designation from FDA for Regenerative Cell Product
10 Jul 2023 //
BUSINESSWIRE
26 Jul 2023 //
BUSINESSWIRE
10 Jul 2023 //
BUSINESSWIRE